Cetrelimab (Anti-PDCD1 / PD-1 / CD279)
Cetrelimab (Anti-PDCD1 / PD-1 / CD279) (A3029-GRP)
Products
Description
Cetrelimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting programmed cell death 1 (PD-1). It inhibits tumor growth in vivo. MW :145.04 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A3029 |